K. Shibata

Angiotensin Receptor Blocker Improves Coronary Flow Velocity Reserve in Hypertensive Patients: Comparison with Calcium Channel Blocker

K. Yamashita, Y. Otsuji, N. Hirakawa, 2007, Hypertension Research.

The anti-HER 3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

K. Nishio, I. Okamoto, K. Okamoto, 2015 .

Tyrosine phosphoproteomics identified both co-drivers and co-targeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer RUNNING TITLE: Phosphoproteomics of EGFR-TKI resistance

E. Haura, I. Okamoto, B. Rawal, 2014 .

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

K. Nishio, I. Okamoto, K. Okamoto, 2014, Oncotarget.

Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer

E. Haura, I. Okamoto, B. Rawal, 2014, Clinical Cancer Research.

Spontaneous Myocardial Infarction in Mice Lacking All Nitric Oxide Synthase Isoforms

Y. Sasaguri, H. Shimokawa, A. Tanimoto, 2008, Circulation.

Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet.

Y. Sasaguri, H. Shimokawa, A. Tanimoto, 2010, Cardiovascular research.

Nitric oxide synthases and heart failure - lessons from genetically manipulated mice.

H. Shimokawa, Y. Otsuji, M. Tsutsui, 2013, Journal of UOEH.

Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases.

Y. Sasaguri, H. Shimokawa, A. Tanimoto, 2010, Circulation journal : official journal of the Japanese Circulation Society.